The National Health Insurance Authority (NHIA) in Nigeria has introduced measures to reduce the financial burden of cancer treatment on patients and their families. As part of these efforts, the authority has expanded insurance support for cancer treatment. This move aims to ensure that health insurance provides meaningful financial protection against high-cost illnesses. The NHIA's initiatives include an arrangement that shields eligible patients from 80 per cent of the cost of selected cancer medicines.
The expanded cost-sharing partnership between the NHIA and pharmaceutical company Roche is a key aspect of this initiative. Under this partnership, Roche bears 50 per cent of the cost of selected oncology medicines, while the NHIA contributes 30 per cent and eligible patients pay the remaining 20 per cent. This arrangement effectively covers 80 per cent of the cost of the selected medicines for beneficiaries. The NHIA has also introduced additional financial support ranging from N400,000 to full coverage for eligible radiotherapy patients.
The NHIA's interventions aim to address the high costs associated with cancer treatment in Nigeria. According to the authority, cancer treatment can impose high costs on households due to repeated diagnostic tests, surgery, chemotherapy, radiotherapy, and specialised medicines. The NHIA's Director-General, Dr Kelechi Ohiri, emphasized that the critical measure of the insurance system should be whether those records provide meaningful protection when illness strikes, rather than merely increasing enrolment figures.
Nigeria faces a significant cancer burden, with an estimated 32,278 new breast cancer cases and 16,332 deaths from the disease annually. Breast cancer remains the most commonly diagnosed cancer among Nigerian women and one of the leading causes of cancer deaths in the country. The NHIA's measures are particularly important in this context, as treatment costs can expose families to prolonged financial pressure.
The NHIA's initiatives complement the Federal Government's broader cancer prevention and treatment programme under the Federal Ministry of Health and Social Welfare. Nigeria is implementing the National Cancer Control Plan 2026–2030, which covers prevention, early detection, diagnosis, treatment, patient navigation, survivorship, research, data management, and expansion of the oncology workforce. The government is also upgrading six Oncology Centres of Excellence across the country.
More than 23 million Nigerians are currently enrolled in the national health insurance system, according to the NHIA. The expanding pool provides a platform for extending interventions for cancer and other high-cost diseases. The authority's interventions include support for screening, surgery, chemotherapy, and follow-up care, as well as mammography, CT and MRI scans, bone scans, laboratory and diagnostic tests, and radiotherapy.
The NHIA has urged women to pay close attention to changes in their breasts, seek medical advice promptly, and take advantage of screening opportunities where available. Reducing deaths and financial hardship from breast cancer will require stronger public awareness, earlier diagnosis, wider access to treatment, and financing mechanisms capable of preventing illness from pushing households into financial distress. The authority acknowledged that the interventions are not sufficient to address the country's cancer burden.
Key points
- The NHIA has expanded insurance support for cancer treatment, aiming to reduce the financial burden on patients and families.
- The authority's initiatives include an arrangement that shields eligible patients from 80 per cent of the cost of selected cancer medicines.
- Nigeria faces a significant cancer burden, with an estimated 32,278 new breast cancer cases and 16,332 deaths from the disease annually.
